Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ·Healthcare·Biotechnology
$19.77
+1.05%
Mkt Cap $1.47B
Analyst Ratings
Buy
8
Hold
0
Sell
0
Price Target (19 analysts)
$32.67
Range $24.00 – $40.00
Implied Upside
+65.3%
Consensus $32.67 vs current $19.77
NASDAQ·Healthcare·Biotechnology
$19.77
+1.05%
Mkt Cap $1.47B
Buy
8
Hold
0
Sell
0
Price Target (19 analysts)
$32.67
Range $24.00 – $40.00
+65.3%
Consensus $32.67 vs current $19.77